Mia Seilern
CHLORHEXIDINE DIGLUCONATE
⚠️ Data is provided for informational purposes only. It may contain inaccuracies and should be independently verified. This is not medical advice. Consult a healthcare professional before making health decisions.

Description: CHLORHEXIDINE DIGLUCONATE — antiseptic, preservative.

All Functions: antiseptic, preservative

Quick Facts:

  • Category: preservative

Proven Benefits At A Glance:

  • Chlorhexidine digluconate is an antiseptic that kills bacteria and fungi directly
  • Allergic reactions are uncommon: only 0.7% of tested patients showed an allergic response
  • When allergic reactions do occur, they’re often clinically relevant and can affect hands, face, or spread across the body
  • It’s particularly effective against Candida albicans, even in established biofilm
  • Standard formulations have limited ability to penetrate deep skin layers where bacteria hide
Safety: Generally Low ConcernResearch confidence: Good

Safety tier is a starting heuristic from regulatory status and comedogenic rating, not a dermatological verdict — see our Terms for the full disclaimer. Research confidence reflects how many real cited studies back this ingredient, not the strength of their findings.

🧪 CHLORHEXIDINE DIGLUCONATE

Chemical structure of CHLORHEXIDINE DIGLUCONATE

CHLORHEXIDINE DIGLUCONATE

CAS Number: 18472-51-0

Also Known As:

Category: preservative

EC Number: 242-354-0

Korean Name: 클로헥시딘다이글루코네이트

D-Gluconic acid, compound with N,N”-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)

CHLORHEXIDINE DIGLUCONATE is a preservative ingredient used in skincare formulations.

antisepticpreservative

🌍 Regulatory Status

EU: No restriction on fileUS: No restriction on file

EU max concentration: 0.3% (as chlorhexidine)

📊 Comedogenicity

No data yet
Not rated for this ingredient yet.

📚 Research & Evidence

PUBMED CITATIONS
5
Data sources: EU CosIng PubMed

🔬 The Science

Chlorhexidine digluconate (CHG) is a cationic bisbiguanide—essentially a positively charged antimicrobial molecule—that works as a broad-spectrum antiseptic (Eur J Pharm Biopharm, 2021). Here’s what the research shows:

#1: Direct antimicrobial action. Chlorhexidine digluconate has a direct killing effect on bacteria and fungi grown both as free-floating cells and within biofilms—structured communities of microorganisms that are typically harder to eliminate (PLoS One, 2020). In laboratory testing against common wound pathogens, formulations containing chlorhexidine digluconate achieved the required level of antimicrobial kill (a ≥3 log reduction, meaning at least a 1,000-fold decrease in viable cells) against Enterococcus hirae and Candida albicans within 10 minutes under moderate conditions, and within 24 hours even under worst-case scenarios with blood, protein, and mucin present to mimic real wound environments (GMS Hyg Infect Control, 2016).

#2: Effectiveness against resistant biofilms. In studies of recurrent vaginal candidiasis, fluconazole (a common antifungal drug) reduced free-floating Candida cells but had no effect on established biofilm. By contrast, chlorhexidine digluconate actively dispersed mature biofilm and killed the candida cells within it, while also preventing formation of new biofilm (PLoS One, 2020). This suggests chlorhexidine digluconate could be valuable where standard antifungals fail. #3: Allergy is uncommon but clinically relevant when it occurs. In a large retrospective study of nearly 15,000 patients patch tested to 1% chlorhexidine digluconate solution, only 107 patients (0.7%) showed an allergic contact dermatitis reaction (Dermatitis, 2023).

However, of those who reacted, 52.3% had clinically relevant reactions—meaning the allergy caused actual symptoms or problems. Most reactions were mild, though some were strong or very strong. The most common source was skin and health care products (38.3% of cases), and occupational exposure was rare except among health care workers. #4: Anatomic patterns of allergic reactions. When allergic contact dermatitis occurred, it most commonly affected the hands (26.4%), face (24.5%), or appeared as scattered/generalized patterns across the body (17.9%) (Dermatitis, 2023). Chlorhexidine-allergic patients were significantly more likely than non-allergic patients to develop dermatitis on the trunk (11.3% vs 5.1%).

#5: Penetration limitations in standard formulations. Despite its effectiveness and favorable safety profile, standard chlorhexidine digluconate formulations like Hibiscrub have poor dermal penetration—bacteria remain protected in deeper skin layers, furrows, and hair follicles that the antiseptic cannot easily reach (Eur J Pharm Biopharm, 2021). Emerging research suggests specialized delivery systems (such as dendrimer-enhanced gels) may improve this penetration in the future. #6: Chemical stability concerns. Chlorhexidine digluconate solutions can degrade when exposed to heat, light, or acidic conditions, producing multiple impurities (Pharm Res, 1993). This is relevant for product stability and shelf life but doesn’t directly impact consumer use of properly stored formulations.

💧 Skin Type Compatibility

No data yet
Per-skin-type data isn’t curated for this ingredient yet.

⚠️ Don’t Combine With

No data yet
No known incompatibilities on file for this ingredient.

🧴 Products Containing CHLORHEXIDINE DIGLUCONATE

📄 Related Research

Matched by search — not necessarily verified support for every statement above.

Similar Ingredients

2-BROMO-2-NITROPROPANE-1,3-DIOL
2-BROMO-2-NITROPROPANE-1,3-DIOL
preservative
View
4-HYDROXYBENZOIC ACID
4-HYDROXYBENZOIC ACID
preservative
View
5-BROMO-5-NITRO-1,3-DIOXANE
5-BROMO-5-NITRO-1,3-DIOXANE
preservative
View
7-ETHYLBICYCLOOXAZOLIDINE
7-ETHYLBICYCLOOXAZOLIDINE
preservative
View
BENZALKONIUM CHLORIDE
BENZALKONIUM CHLORIDE
preservative
View
BENZOIC ACID
BENZOIC ACID
preservative
View
BENZYL ALCOHOL
BENZYL ALCOHOL
preservative
View
CAPRYLHYDROXAMIC ACID
CAPRYLHYDROXAMIC ACID
preservative
View